Reagents Madigan Military Treatment Facility
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest special notice from .
- Solicitation number
- PANHCA25P0000006440
- Agency
-
Medical Command
Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Washington 98431, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of the Army Medical Command is conducting a sources sought notice for coagulation analyzers and reagents for the Madigan Army Medical Center at Joint Base Lewis McChord, Washington. The procurement requires two fully automated random access coagulation analyzers with a minimum throughput of 50 tests per hour, capable of performing various coagulation tests including Prothrombin Time, Activated Partial Thromboplastin Time, Fibrinogen, and D-Dimer. The system must be compatible with Roche's Total Laboratory Automation (TLA) Line and include comprehensive maintenance, training, and support services. Eligible vendors must be authorized distributors of the Original Equipment Manufacturer and qualify under NAICS code 325413 with a small business size standard of 1,000 employees. Interested parties must submit responses by June 20, 2025, to wanda.f.williams35.civ@health.mil with specific organizational information including CAGE code, Unique Entity ID, and OEM authorization letter. The government emphasizes this is strictly a market research effort and not a solicitation for quotations or proposals.
This opportunity does not utilize any set-aside designation and no incumbent contractors are identified in the notice. The annual estimated workload includes significant testing volumes with 28,000 Prothrombin Time tests and 19,000 Activated Partial Thromboplastin Time tests among various other specialized coagulation assays. The contract requires strict service level agreements including emergency response within 4 hours and repair completion within 48 hours of service calls. The system must achieve FDA approval for new equipment, complete method validation per clinical standards, and obtain cybersecurity Authority to Operate (ATO) certification within six months of contract award. Additionally, the contractor must provide 24/7 maintenance and support services along with comprehensive training for medical technicians. No specific contract value or award amount is disclosed in the pre-solicitation documentation.
Notice text
See Attached Sources Sought and Draft Statement of Work
Files
| File | Type | Posted |
|---|---|---|
| Sources Sought .docx | DOCX document | |
| Draft_ SOW Coagulation Reagents.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| STA R Max and Compact Max Coagulation Instruments | Award Notice | |
| STA R Max and Compact Max Coagulation Instruments | Special Notice | |
| This notice | Pre-Solicitation |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity